"Safety of dupilumab in atopic patients during COVID-19 outbreak." Journal of Dermatological Treatment, 33(1), pp. 600–601
Disclosure statement
M.N. acted as speaker for Sanofi. C.P. acted as speaker and consultant for AbbVie, Novartis, Pfizer and Sanofi. G.F. acted as speaker and consultant for AbbVie and Leo Pharma.